Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

51.06
+0.77001.53%
Post-market: 50.00-1.0600-2.08%18:15 EDT
Volume:3.08M
Turnover:156.42M
Market Cap:103.28B
PE:16.33
High:51.08
Open:50.72
Low:50.62
Close:50.29
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.18
T/O Rate:0.16%
Dividend:1.82
Dividend Rate:3.56%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.38
PE(LYR):13.67

Loading ...

GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight

TIPRANKS
·
Jul 16

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?

Simply Wall St.
·
Jul 15

GSK Completes $10.6 Billion Acquisition of Nuvalent

MT Newswires Live
·
Jul 15

GSK Slides Tuesday, Underperforms Market

Dow Jones
·
Jul 15

GSK Executives Acquire Shares Under Routine Reward Plan

TIPRANKS
·
Jul 13

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13

GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients

TIPRANKS
·
Jul 13

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13

Guggenheim Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 10

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

TIPRANKS
·
Jul 10

Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen

Deep News
·
Jul 10

GSK price target raised to 1,950 GBp from 1,900 GBp at Deutsche Bank

TIPRANKS
·
Jul 10

GSK US President Acquires Notional ADS Under Executive Savings Plan

TIPRANKS
·
Jul 09

GSK Adds Philips CEO Roy Jakobs to Board as Independent Director

TIPRANKS
·
Jul 09

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Deep News
·
Jul 09

Alector Ends GSK Collaboration, Retires Hercules Capital Debt

TIPRANKS
·
Jul 09

GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio

TIPRANKS
·
Jul 09

GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad

TIPRANKS
·
Jul 09

GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside

TIPRANKS
·
Jul 09

GSK Advances New Malaria Drug With Completed First-in-Human Study

TIPRANKS
·
Jul 09